Top Vadodara officials take second dose of Corana vaccine

India: Coronavirus vaccine ‘Covaxin’ shows strong immune response in its 1st phase clinical trials

<p>India’s indigenous coronavirus vaccine, Covaxin, has shown to generate strong immune response in its first phase clinical trials. A detailed immunogenicity response of the first phase trials of the vaccine has been declared by the manufacturers. Covaxin, jointly developed by Hyderabad based Bharat Biotech and ICMR has been found to be safe generating no serious […]</p>